Published • loading... • Updated
Niowave Adding $75M Facility in Lansing to Boost Isotopes Used in Cancer Therapies
Summary by DBusiness Magazine
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Niowave Adding $75M Facility in Lansing to Boost Isotopes Used in Cancer Therapies
Niowave has broken ground on a $75 million production facility in Lansing to expand its manufacturing footprint and strengthen the domestic supply of Actinium 225 (Ac 225), a critical isotope used in next generation targeted cancer therapies. // Rendering courtesy of Niowave Niowave has broken ground on a $75 million production facility in Lansing to expand its manufacturing footprint and strengthen the domestic supply of Actinium‑225 (Ac‑225), …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
